AuntMinnie.com staff writers

AI
Raidium unveils AI-native PACS viewer at RSNA 2025
French precision radiology developer Raidium unveiled its work-in-progress AI-native PACS viewer at RSNA 2025.
December 10, 2025
Artificial Intelligence Ai Binary Code
AI
A2z raises $4.5M in seed round for CT triage system
A2z Radiology has raised $4.5 million in a seed round for R&D and the commercial deployment of its abdominal/pelvic CT triage algorithm.
December 9, 2025
Computer Brain Money 400
AI
Lunit submits 510(k) to U.S. FDA for breast cancer risk prediction model
The model estimates a woman's breast cancer risk from screening mammograms.
December 8, 2025
Lunit
Economics
ACR highlights 2026 HOPPS imaging-specific changes
The American College of Radiology (ACR) has created a summary of imaging-specific changes included in the 2026 HOPPS final rule.
December 5, 2025
Acr Logo 2023
CT
mlHealth 360 secures FDA 510(k) for ICH triage tool
mlHealth 360 has received U.S. Food and Drug Administration (FDA) clearance for its Scaida BrainCT-ICH AI-powered triage software.
December 5, 2025
Am 2022 07 21 18 24 3896 Computer Brain Hemisphere 400
Economics
Lumexa Imaging launches IPO seeking up to $500M
Lumexa Imaging Holdings has set the price for its initial public offering (IPO) between $17 and $20 per share.
December 5, 2025
Dollars Pile
Radiation Oncology/Therapy
GE HealthCare inks RT, AI partnerships
GE HealthCare
GE HealthCare announced two key collaborations for its existing and new imaging technology at RSNA 2025.
December 5, 2025
Ge Hc Logo 400
Augmented/Virtual Reality
MediView obtains CE Mark for OmnifyXR Interventional Suite
MediView has obtained a CE Mark for OmnifyXR Interventional Suite, the first CE Mark for the company.
December 4, 2025
Medi View Xr90 Augmented Reality Based Visualization And Navigation Platform
CT
Mars Bioimaging photon-counting CT scanner lands in Prague
Mars Bioimaging has sold a spectral photon counting CT scanner to Charles University in Prague, the Czech Republic.
December 4, 2025
Mars Microlab Scanner Thumbnail
Digital X-Ray
Konica Minolta Healthcare debuts two new digital systems at RSNA
Konica Minolta Healthcare is debuting two new floor-mounted digital radiography systems at RSNA.
December 3, 2025
KDR FMT+
Page 1 of 220
Next Page
Top Stories
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Molecular Imaging
Phase I trial reveals the potential of a new PSMA-PET tracer
The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
Womens Imaging
Radiologists can designate nonmass lesions on breast ultrasound
Coronavirus
MRI
Long COVID's neurological effects persist
Obesity Text2
MRI
MRI proves effective for tracking results of obesity interventions
Phpt
Molecular Imaging
TVR-PET/CT shows promise in primary hyperparathyroidism
More in Home
Phase I trial reveals the potential of a new PSMA-PET tracer
By Will Morton
The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.
December 9, 2025
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Radiologists can designate nonmass lesions on breast ultrasound
By Amerigo Allegretto
Breast radiologists achieved moderate to substantial interreader agreement for classifying nonmass lesions on ultrasound.
December 9, 2025
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
Long COVID's neurological effects persist
By Kate Madden Yee
Long COVID is typically defined as persistent symptoms beyond four weeks from onset of the illness.
December 9, 2025
Coronavirus
MRI proves effective for tracking results of obesity interventions
By Kate Madden Yee
MRI is a powerful tool to monitor skeletal muscle adaptations during lifestyle interventions for obesity, researchers noted.
December 8, 2025
Obesity Text2
TVR-PET/CT shows promise in primary hyperparathyroidism
By Will Morton
Gallium-68 trivehexin PET/CT was superior for identifying lesions over technetium-99m sestamibi SPECT.
December 8, 2025
Phpt
ACR talks BI-RADS version 2025 with AuntMinnie
By Amerigo Allegretto
ACR members discussed the need to release the latest version of BI-RADS and what changes breast radiologists can expect.
December 8, 2025
Acr Logo 2023 400
ACR's Ted Burnes talks advocacy in radiology with AuntMinnie
By Amerigo Allegretto
Ted Burnes from the American College of Radiology spoke with AuntMinnie on achievements in advocacy and what 2026 may bring.
December 8, 2025
Screenshot (91)
PiB-PET/CT detects subtypes in cardiac amyloidosis
By Will Morton
PiB-PET/CT shows strong promise as a next-generation diagnostic tool for cardiac amyloidosis.
December 5, 2025
Heart
HPI: 13.5B mL of contrast media administered from 2011 to 2024
By Kate Madden Yee
The findings are sobering, as contrast use contributes to environmental pollution.
December 5, 2025
Contrast Injector
AI ultrasound tool could reduce unnecessary biopsies by 60%
By Amerigo Allegretto
An AI tool could help reduce unnecessary breast biopsies, but should be used in conjunction with radiologist decision-making.
December 5, 2025
2025 12 05 Ai Decision Support Tool Ultrasound Thumbnail
3D CNN model estimates MACE risk from chest CT
By Kate Madden Yee
The algorithm appears effective at predicting major adverse cardiovascular events (MACE) even when applied to diverse patient groups.
December 5, 2025
Lung Ct Images
What is the role of AI quantitation of coronary plaque?
By Liz Carey
Tracking coronary artery calcium score alone is not enough, according to an RSNA presentation.
December 4, 2025
Rsna 2025 Welcome
Page 1 of 190
Next Page